Results 251 to 260 of about 2,510,208 (357)

Factor analysis and correlation between CIWA-Ar protocol and biochemical-hematic profile in patients with alcohol withdrawal syndrome

, 2015
L. Carcaño-Calderón, Christian Omar Ramos Peñafiel, Mario Salcedo-Roldán, I. Díaz-Estrada, Francisco Galván-Flores, Raymundo Durán-Guzmán, F. Sandoval-Gutiérrez, Carlos Alberto Mendoza-García, Adrián Santoyo-Sánchez, Carlos Martínez‐Murillo, Juan Collazo-Jaloma   +10 more
openalex   +1 more source

Dexmedetomidine as Adjunctive Therapy for the Treatment of Alcohol Withdrawal Syndrome: A Systematic Review and Meta-Analysis. [PDF]

Pharmaceuticals (Basel)
Fiore M, Alfieri A, Torretta G, Passavanti MB, Sansone P, Pota V, Simeon V, Chiodini P, Corrente A, Pace MC.   +9 more
europepmc   +1 more source

Long‐Term Improvements of Complex Post‐Traumatic Stress Disorder (CPTSD) Symptoms After Multimodal Psychodynamic Inpatient Rehabilitation Treatment–An Observational Single Center Pilot Study

Journal of Clinical Psychology, EarlyView.
ABSTRACT Background Complex post‐traumatic stress disorder (CPTSD) is a severely disabling mental health condition, frequently observed in survivors of prolonged, repeated or multiple traumatic stressors. While studies indicate that engaging in psychotherapy can reduce CPTSD symptom severity, data on long‐term effectiveness of interventions is scarce ...
David Riedl, Jürgen Thaler, Christina Kirchhoff, Hanna Kampling, Johannes Kruse, Tobias Nolte, Chloe Campbell, Vincent Grote, Michael J. Fischer, Astrid Lampe   +9 more
wiley   +1 more source

Hospital Readmissions Among Infants With Neonatal Opioid Withdrawal Syndrome.

JAMA Netw Open
Gaither JR, Drago MJ, Grossman MR, Li Y, Shabanova V, Xu X, Leventhal JM.   +6 more
europepmc   +1 more source

Effects of Hepatic or Renal Impairment on Pharmacokinetics of Fruquintinib

The Journal of Clinical Pharmacology, EarlyView.
Abstract Fruquintinib (FRUZAQLATM) is a highly selective tyrosine kinase inhibitor of all three vascular endothelial growth factor receptors (‐1, ‐2, and ‐3). Two Phase 1, open‐label, single‐dose studies investigated the impact of hepatic or renal impairment on the pharmacokinetics and tolerability of fruquintinib.
Martha Gonzalez, Zhao Yang, William Schelman, Thomas C. Marbury, Juan C. Rondon, William Smith, Xiaofei Zhou, Neeraj Gupta, Caly Chien   +8 more
wiley   +1 more source

Incidence of Hospitalizations Involving Alcohol Withdrawal Syndrome in a Primary Care Population.

JAMA Netw Open
Steel TL, Matson TE, Hallgren KA, Oliver M, Jack HE, Berger D, Bradley KA.   +6 more
europepmc   +1 more source

Phenobarbital Dosing for the Treatment of Alcohol Withdrawal Syndrome: A Review of the Literature. [PDF]

J Pharm Technol
Brooks L, Reinert JP.
europepmc   +1 more source

Emotion and peer problems in autistic adolescents: The role of puberty, school adjustment and bullying

JCPP Advances, EarlyView.
Abstract Background Emotion and peer problems tend to increase in autistic young people during adolescence. However, the extent to which endogenous (e.g., pubertal maturation) and exogenous (e.g., school adjustment, bullying) factors contribute to trajectories of emotion and peer problems in autistic young people is unclear. Methods Using data from the
Erin O. Dawe‐Lane, Rob Saunders, Eirini Flouri, William P. L. Mandy   +3 more
wiley   +1 more source

Exploring core symptoms of alcohol withdrawal syndrome in alcohol use disorder patients: a network analysis approach. [PDF]

Front Psychiatry
Shen G, Chen YH, Wu Y, Jiahui H, Fang J, Jiayi T, Yimin K, Wang W, Liu Y, Wang F, Chen L.   +10 more
europepmc   +1 more source

Systematic review: Safety and efficacy of atomoxetine in children and adolescents with autism spectrum disorder

JCPP Advances, EarlyView.
This systematic review aimed to assess the current evidence on the efficacy and safety of Atomoxetine in common clinical symptoms of autism spectrum disorder (ASD) for children and adolescents. With limited studies available, there is a need for more high‐power studies for the use of Atomoxetine in children and adolescents with autism spectrum disorder.
Nihit Gupta, Daniel Boyes, Hunter Hanlon‐Taylor, Mayank Gupta   +3 more
wiley   +1 more source